Robotic Cataract Surgery Using ForSight Robotics’
ORYOMtm Platform Presented For the First Time at the ASCRS Annual Meeting
Dr. David F. Chang, 2024 Kelman Innovator Lecturer,
Presented the Cataract Surgery Robotics Platform at ASCRS Conference
BOSTON, April 15, 2024 – The first-of-its-kind robotic cataract procedure on a porcine eye was presented atthe 2024
During his Charles D. Kelman Innovator Lecture, Dr. Chang discussed his
“This is the first time I’m showing a video of me operating on an animal eye, doing the entire procedure with robotic arms, while sitting at a workstation located 20 ft. away from the eye. The robotic arms were precisely mirroring what my hands were doing.”
David F. Chang, M.D. is recognized as one of the world’s top cataract surgeons. He has pioneered, developed and taught many surgical strategies for complex and complicated cataract cases and has championed the need for innovative solutions to combat global cataract blindness and advance sustainability in ophthalmology. Dr. Chang, a clinical professor at the University of California, San Francisco, ranked #5 in the 2023 “Power List” of the 100 most influential ophthalmologists as selected by The Ophthalmologist. Dr. Chang chairs the ForSight Robotics Clinical Advisory Board, and has published more than 160 papers worldwide. He has been in private practice in Los Altos, California since 1984 and was ranked #3 in Newsweek’s list of the best United States ophthalmologists for both 2022 and 2023.
“This was an exciting milestone for us – debuting a cataract procedure that has not yet been presented in a public conference forum,” says ForSight Co-Founder, President, and Chief Medical Officer Dr. Joseph Nathan. “With the expertise and support of world-renowned cataract surgeons like Dr. Chang, we are seeking to transform the future of sight-saving eye surgery.”
About the ORYOMTM Surgical Robotics Platform:
ForSight Robotics’ ORYOMTM Surgical Robotics Platform is being developed to amplify surgeons’ skills and to increase patient access to sight-saving surgery, worldwide. Utilizing AI-based algorithms, robotics, and advanced computer vision, the ORYOMTM Platform has already completed dozens of full robotic cataract procedures (on an animal eye model). ForSight’s technology is backed by leading investors, surgical robotics experts, and prominent ophthalmic surgeons who are guiding the product development alongside the talented team. The Strategic Advisory Board includes Dr. Fred Moll (founder of Intuitive Surgical and Auris Health) and Rony Abovitz (founder of Mako Surgical and Magic Leap), and the Clinical Advisory Board which includes Dr. David Chang, Dr. Vance Thompson, Dr. Elizabeth Yeu, Prof. Boris Malyugin, Dr. Sam Garg, and Dr. Modi Naftali.
About ForSight Robotics:
ForSight Robotics is a surgical robotics company pioneering world-class technology to democratize quality surgical eye care. The Israel-based company is developing the ORYOMTM (“daylight” in Hebrew) Platform, the world’s first robotic surgery platform for cataracts and widespread eye diseases, which will utilize AI-based algorithms, advanced computer vision, and miniaturized-mechanics. ForSight Robotics has been recognized with Fast Company World Changing Ideas Award, LinkedIn Top Israeli Startups, and Fierce MedTech 15 List, among others. Backed by globally recognized VCs and industry leaders, ForSight Robotics is redefining ophthalmic surgery and bringing hope to millions of patients worldwide. To learn more, visit forsightrobotics.com and follow us on LinkedIn.